Zheng-Jie Xu
Overview
Explore the profile of Zheng-Jie Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fang K, Xu Z, Jiang S, Tang D, Yan C, Deng Y, et al.
Mol Med Rep
. 2025 Feb;
31(4).
PMID: 39950317
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the cell migration and invasion assay data shown in Fig....
2.
Fang K, Xu Z, Jiang S, Tang D, Yan C, Deng Y, et al.
Mol Med Rep
. 2021 Apr;
23(6).
PMID: 33880593
Breast cancer is the second most prevalent cancer in women worldwide. Long non‑coding RNAs (lncRNAs) have been identified as important regulators of tumorigenesis and tumor metastasis. lncRNA FGD5‑AS1 has been...
3.
Liu X, Pan Q, Zhang R, Shen F, Yan S, Sun C, et al.
World J Gastroenterol
. 2016 Dec;
22(44):9844-9852.
PMID: 27956809
Aim: To assess disease-specific circulating microRNAs (miRNAs) in non-alcoholic steatohepatitis (NASH) patients. Methods: A total of 111 biopsy-proven non-alcoholic fatty liver disease (NAFLD) or chronic hepatitis B (CHB) patients and...
4.
Xu Z, Shi J, Yu D, Zhu L, Jia J, Fan J
Adv Ther
. 2016 Oct;
33(11):2069-2081.
PMID: 27743352
Introduction: Non-alcoholic steatohepatitis (NASH) is a serious form of non-alcoholic fatty liver disease (NAFLD) that can progress to advanced fibrosis, cirrhosis, and hepatocellular carcinoma. Differentiating between non-alcoholic fatty liver (NAFL)...
5.
Xu Z, Zhao G, Wang Q, Che C, Jiang N, Hu L, et al.
Int J Ophthalmol
. 2012 Sep;
5(4):409-14.
PMID: 22937496
Aim: To investigate the expression of nucleotide oligomerization domain 2 (NOD2) in the immortalized human corneal epithelial cell line (THCE), and its role in the innate immune response triggered by...
6.
Xia X, Xu Z, Hu X, Wu C, Dai Y, Yang L
Cell Biochem Funct
. 2012 Feb;
30(4):279-85.
PMID: 22290599
Nitric oxide (NO) is an important vascular modulator in the development of pulmonary hypertension. NO exerts its regulatory effect mainly by activating soluble guanylate cyclase (sGC) to synthesize cyclic guanosine...
7.
Wan X, Xu Z, Zhu F, Li L
Hepatobiliary Pancreat Dis Int
. 2011 Aug;
10(4):403-7.
PMID: 21813390
Background: Clinically, common bile duct (CBD) stones >2 cm are difficult to remove by endoscopic retrograde cholangiopancreatography (ERCP). To evaluate this observation, the rates of successful clearance of CBD stones...
8.
Xia X, Xu Z, Bi Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2011 Jan;
19(2):159-60.
PMID: 21207666
No abstract available.
9.
Jin X, Xu Z, Wang W, Xu Y, Zhang X
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2010 Dec;
25(1):41-4.
PMID: 21186612
Aim: To investigate protective effects of polydatin(PD) during lung ischemia/reperfusion in rabbits and its potential mechanisms. Methods: Rabbit lung model of ischemia/reperfusion (I/R) injury was constituted in vivo. Thirty rabbits...
10.
Wang W, Zhou W, Ni S, Xu Z
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2010 Dec;
21(4):427-31.
PMID: 21180165
Aim: To explore the effect of ligustrazine injection on the expression of heme oxygenase-1 (HO-1) in rabbits with pulmonary ischemia/reperfusion injury after. Methods: Single lung ischemia/reperfusion injury animal model was...